CIK 0002104204 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Alamar Biosciences, Inc.
Sign in to watch- Ticker
- ALMR
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364899036
- Phone
- 510-626-9888
- Business address
- 47071 BAYSIDE PARKWAY, FREMONT, CA, 94538
- 4 Open-market sale 10% owner sold 111,313 shares at $29.89 ($3,327,146)
- 10-Q Report Quarterly Report
- 4 Open-market sale 10% owner sold 187,636 shares at an average $30.25 ($5,676,413)
- 8-K Event Results of operations · Executive or director change
- 4 Open-market sale 10% owner sold 185,731 shares at an average $32.14 ($5,968,888)
- 4 Open-market sale 10% owner sold 280,458 shares at an average $30.56 ($8,569,760)
- 4 Open-market sale 10% owner sold 342,626 shares at an average $29.93 ($10,253,095)
- 4 Open-market sale 10% owner sold 217,512 shares at an average $27.35 ($5,949,983)
- 4 Open-market sale 10% owner sold 173,673 shares at an average $27.73 ($4,816,121)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Grant or award General Counsel acquired 29,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 5,686 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
Page 1 of 4 · 63 filings